Human cytochromes mediating gepirone biotransformation at low substrate concentrations
- 13 January 2003
- journal article
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 24 (2) , 87-94
- https://doi.org/10.1002/bdd.340
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Human Drug Metabolism and the Cytochromes P450: Application and Relevance of In Vitro ModelsThe Journal of Clinical Pharmacology, 2001
- Effects of the Antifungal Agents on Oxidative Drug MetabolismClinical Pharmacokinetics, 2000
- The use of heterologously expressed drug metabolizing enzymes— state of the art and prospects for the futurePharmacology & Therapeutics, 1999
- Relative Quantities of Catalytically Active CYP 2C9 and 2C19 in Human Liver Microsomes: Application of the Relative Activity Factor ApproachJournal of Pharmaceutical Sciences, 1998
- Five Distinct Human Cytochromes Mediate Amitriptyline N‐Demethylation In Vitro: Dominance of CYP 2C19 and 3A4The Journal of Clinical Pharmacology, 1998
- Gepirone in Depression and Anxiety DisordersCNS Drugs, 1994
- Effect of Food on the Bioavailability of Gepirone in HumansThe Journal of Clinical Pharmacology, 1993
- Alprazolam Metabolism in vitro: Studies of Human, Monkey, Mouse, and Rat Liver MicrosomesPharmacology, 1993
- The Site of Gastrointestinal Absorption of Gepirone in HumansThe Journal of Clinical Pharmacology, 1992
- Serotonergic mechanisms in the behavioral effects of buspirone and gepironePharmacology Biochemistry and Behavior, 1986